Acacia gum in chronic renal failure
New hope for the supply-and-demand crisis of kidney transplantation?
Discovery of stroke-vulnerable neurons could lead to targeted stroke therapy
Intensive therapy shows promise in the relief of diabetic neuropathy
Taste receptors living outside the body?
Persistent nerve injury to blame for complex regional pain syndrome-I
Lower doses of tissue plasminogen activator are safer
Testosterone shown to improve quality of life in men with Alzheimer's disease
Infliximab
Enteric-coated mycophenolate sodium
Trospium chloride
Esomeprazole
Tamsulosin – modified-release and oral-controlled absorption system formulations in the treatment of benign prostatic hyperplasia
Roflumilast for the treatment of chronic obstructive pulmonary disorder
Second-line treatment for Helicobacter pylori eradication after sequential therapy failure
Preoperative manometry is not a predictor of postoperative dysphagia in chagasic achalasia
Population pharmacokinetic analysis of the microemulsion formulation of cyclosporin A (Neoral®) in renal transplant patients
Continuous renal replacement in the developing world
Rehabilitation of the younger adult stroke patient
Substance P and swallowing after stroke
Foreword
Principles
The conservative management of nonterminal chronic renal failure
Management of end-stage renal failure
Acacia gum (gum arabic)
A step towards the introduction of acacia gum as a medicine
Scientific evidence
Discussion points